StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

21-Chlor-9-fluor-11β,17-dihydroxy-16β-methylpregna-1,4-dien-3,20-dion-17-propionat

Clobetasol Propionate

HCID 32798
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
25122-46-7
Standard-SMILES
CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
InChIKey
CBGUOGMQLZIXBE-XGQKBEPLSA-N
Summenformel
C25H32ClFO5
Durchschnittliche Molmasse
467 g/mol
Monoisotopische Masse
466,19223

Überblick

Clobetasol Propionate can cause developmental toxicity and female reproductive toxicity according to state or federal government labeling requirements.

Namen und Bezeichner

Bevorzugter Name
Clobetasol Propionate
IUPAC
[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
Lokaler Name
21-Chlor-9-fluor-11β,17-dihydroxy-16β-methylpregna-1,4-dien-3,20-dion-17-propionat
Englischer Name
Clobetasol propionate
Summenformel
C25H32ClFO5
Molmasse
466.97

Namen und Synonyme

CLOBETASOL PROPIONATE25122-46-7Clobetasol 17-propionateClobexDermovateTemovateEmbelineCormaxOluxEmbeline ETemovate EOlux-E
Weitere Namen anzeigen
CLOBETASOLE PROPIONATECLOBETASOL-17-PROPIONATE17-propionateClobetazole propionate21-Chloro-9-fluoro-11b,17-dihydroxy-16b-methylpregna-1,4-diene-3,20-dione 17-propionate
ImpoyzPsorexCCI 4725GR 2/925clobetasol 17-propanoateOlux EClareluxDovate

Datenbank-Bezeichner

CAS
25122-46-7
PubChem CID
32798
DTXSID
DTXSID6045907
ChEMBL
CHEMBL1159650
ChEBI
CHEBI:31414

Eigenschaften

Berechnete Struktureigenschaften

XLogP
3,8
Polarare Oberfläche (TPSA)
80,7 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
5
Schwere Atome
32
Formalladung
0
Komplexität
929

Experimentelle und physikochemische Eigenschaften

Drugs · 2 Einträge

Pharmaceuticals -> Dermatologicals -> Corticosteroids, dermatological preparations

Pharmaceuticals -> Listed in ZINC15

LogP3.18
Human Drugs · 3 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Pharmaceuticals

Endocrine DisruptorsPotential endocrine disrupting compound
Collision Cross Section205.1 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
195.5 · 195.5-1970C
Siedepunkt
569 · 569.0±50.0 °C(Predicted)
Dichte
1.1653 · 1.1653 (estimate)
storage temp.
2 · Keep in dark place,Sealed in dry,2-8°C

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H315 (34.1%): Causes skin irritation [Warning Skin corrosion/irritation]

P203, P260, P261, P264, P264+P265, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 91 reports by companies from 19 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory Information · 2 Einträge

Hazard Traits - Developmental Toxicity; Reproductive Toxicity

Clobetasol propionate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11.beta.,16.beta.)-: Environment tier I assessment
Hazard Classes and CategoriesSkin Irrit. 2 (34.1%)

Sicherheitsdaten

wgk
2
hs_code
29372290
RTECS-Nr.
TU3725000
risk_code
36/37/38-62-53-48/20/21-61
hazard_code
Xi,T
safety_code
26-36-45-36/37-53
Speicherklasse
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

Chemie und Industrie

Pharmakologische Informationen

Protein BindingData regarding the protein binding of clobetasol propionate are not readily available. Corticosteroids are generally bound to corticosteroid binding globulin and serum albumin in plasma.
Pharmacodynamics · 1 Eintrag

Corticosteroids bind to the glucocorticoid receptor, inhibiting pro-inflammatory signals, and promoting anti-inflammatory signals. Clobetasol propionate is generally applied twice daily so the duration of action is long. Corticosteroids have a wide therapeutic window as patients may require doses that are multiples of what the body naturally produces. Patients taking corticosteroids should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.

Mechanism of Action · 1 Eintrag

The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation. Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days. Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10. Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive. High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.

Biological Half-LifeData regarding the half life of clobetasol propionate are not readily available.
Metabolism/Metabolites · 1 Eintrag

The metabolism of clobetasol propionate is not well studied but it does induce metabolic enzymes, even when delivered topically. The metabolism of clobetasol propionate is predicted to follow similar metabolic pathways to other corticosteroids including the addition of oxygen, hydrogen, glucuronides, and sulfates to form water soluble metabolites.

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
UNII
779619577M
EC Number
246-634-3
Nikkaji
J21.005F
Löslichkeit
Practically insoluble in water, freely soluble in acetone, sparingly soluble in ethanol (96 per cent).
pka
12.88 · 12.88±0.70(Predicted)
Aggregatzustand
Solid
Farbe
White to off-white
Major Application
forensics and toxicologyveterinary
InChIKey
CBGUOGMQLZIXBE-XGQKBEPLSA-N
SMILES
O([C@@]1([C@H](C[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C)C(=O)CCl)C(=O)CC |&1:1,2,4,6,16,18,20,23,r|
CAS Datenbank
25122 · 25122-46-7(CAS DataBase Reference)
Hazard Classifications
Aquatic Chronic 4Repr. 1BSTOT RE 2
FDA Pharmacological Classification · 6 Einträge

CLOBETASOL PROPIONATE

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

CLOBETASOL PROPIONATE CREAM USP, 0.05%

Corticosteroid [EPC]; Corticosteroid Hormone Receptor Agonists [MoA]

CLOBETASOL PROPIONATE OINTMENT USP, 0.05%

Corticosteroid [EPC]; Corticosteroid Hormone Receptor Agonists [MoA]

MeSH Pharmacological Classification · 2 Einträge

Substances that reduce or suppress INFLAMMATION.

A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.

Absorption, Distribution and Excretion · 4 Einträge

Twice daily application of clobetasol foam leads to a Cmax of 59±36pg/mL with a Tmax of 5 hours. Clobetasol cream showed an increase in clobetasol concentrations from 50.7±96.0pg/mL to 56.3±104.7pg/mL.

Corticosteroids are eliminated predominantly in the urine.

Data regarding the volume of distribution of clobetasole propionate are not readily available.

Data regarding the clearance of clobetasol propionate are not readily available.

Verwendung und Herstellung

Use ClassificationPharmaceuticals
Anwendungen · 1 Eintrag

VerwendenTopical corticosteroid. Glucocorticoid; anti-inflammatory. Clobetasol propionate (Cormax, Temovate, Embeline, Olux) is one of the most potent of the currently available agents and is indicated for short-term treatment of inflammatory or hyperplastic disorders. It is a synthetic fluorinated corticosteroid. It may cause a more rapid or prolonged response than other topical corticosteroids. It is recommended that clobetasol have a maximum application of 60 g/week for no longer than 14 days without occlusion and that it should not be used in children below age 12.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

PropionsureanhydridLithiumchlorid

Ergänzende Hinweise

DefinitionChEBI: The 17-O-propionate ester of clobetasol. A potent corticosteroid, it is used to treat various skin disorders, including exzema and psoriasis.